Diametric Capital’s Intersect ENT, Inc XENT Stock Holding History

Diametric Capital’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15,000	Closed	-$420K	–	401
2022 Q1	$420K	Buy	15,000 +6,494	+76%	+$178K	0.23%	118
2021 Q4	$232K	Buy	+8,506	New	+$231K	0.18%	117
2018 Q3	–	Sell	-8,964	Closed	-$336K	–	129
2018 Q2	$336K	Sell	8,964 -13,211	-60%	-$519K	0.32%	64
2018 Q1	$871K	Buy	22,175 +13,401	+153%	+$490K	0.66%	55
2017 Q4	$284K	Buy	+8,774	New	+$263K	0.17%	100

Diametric Capital's XENT Position: Q2 2022 in Review

Diametric Capital sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 15,000 shares — an estimated $420K sold.

Diametric Capital first reported a position in XENT in Q4 2017 and held it in 5 quarters. The position peaked at $871K in Q1 2018. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Diametric Capital reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Diametric Capital sold 15,000 Intersect ENT, Inc shares in Q2 2022, an estimated $420K.
Diametric Capital first reported a position in Intersect ENT, Inc in Q4 2017 and held it in 5 quarters.
Diametric Capital's Intersect ENT, Inc position peaked at $871K in Q1 2018.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Diametric Capital's 13F filing for Q2 2022, filed 15 Aug 2022.